Invo Bioscience Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Invo bioscience inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Invo Bioscience Inc Today - Breaking & Trending Today

INVO Bioscience, Inc. (NASDAQ:INVO) Short Interest Up 146.4% in May

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 81,300 shares, an increase of 146.4% from the April 30th total of 33,000 shares. Approximately 2.2% of the company’s shares are short sold. […] ....

United States , Bioscience Inc , Sabby Management , Invo Bioscience Inc , Get Free Report , Free Report ,

INVO Reports Record First Quarter 2024 Financial Results

INVO Reports Record First Quarter 2024 Financial Results
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Steve Shum , Invo Bioscience Inc , Securities Exchange , Bioscience Inc , Robert Blum Lytham Partners , Biosciences Inc , Record First Quarter , Preferred Stock , Securities Act , Securities Exchange Act , Private Securities Litigation Reform Act , Invo Bioscience , Lytham Partners ,

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Declines By 80.3%

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant decline in short interest during the month of November. As of November 30th, there was short interest totalling 196,700 shares, a decline of 80.3% from the November 15th total of 997,200 shares. Based on an average daily volume of 3,830,000 shares, […] ....

United States , Virtu Financial , Bioscience Company Profile , Sabby Management , Bioscience Inc , Armistice Capital , Invo Bioscience Inc , Vanguard Group Inc , Get Free Report , Stock Down , Invo Bioscience , Nasdaq Invo ,

Short Interest in INVO Bioscience, Inc. (NASDAQ:INVO) Increases By 397.4%

INVO Bioscience, Inc. (NASDAQ:INVO – Get Free Report) was the target of a significant increase in short interest in October. As of October 31st, there was short interest totalling 289,000 shares, an increase of 397.4% from the October 15th total of 58,100 shares. Based on an average daily volume of 1,840,000 shares, the short-interest ratio […] ....

United States , Bioscience Inc , Armistice Capital , Invo Bioscience Inc , Vanguard Group Inc , Virtu Financial , Bioscience Company Profile , Get Free Report , Invo Bioscience , Nasdaq Invo ,

INVO Bioscience (INVO) and NAYA Appoints Peter Kash as Vice Chairman Following Closing of Their Pending Merger

INVO Bioscience (INVO) and NAYA Appoints Peter Kash as Vice Chairman Following Closing of Their Pending Merger
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United States , Prentice Hall , Shearson Lehman Hutton , Daniel Teper , Peter Kash , Edgemont Pharmaceuticals , Biosciences Inc , Intercept Pharmaceuticals , Professor At Hebrew University , Invo Bioscience Inc , International Banking , Professor Of Marketing At Polytechnic University , Wharton Business School , Lubin School Of Business At Pace University , Azrieli Graduate School Of Yeshiva University , River Group , School Of Business At Nihon University , Vice Chairman , Targimmune Therapeutics , Managing Director , Two River Group , Riverbank Capital Securities , Kite Pharma , Polarx Biopharmaceuticals , Associate Professor , Adjunct Professor ,